Capricor Therapeutics
CAPR
#7633
Rank
C$0.63 B
Marketcap
C$10.88
Share price
0.80%
Change (1 day)
34.25%
Change (1 year)

EPS for Capricor Therapeutics (CAPR)

EPS in 2026 (TTM): C-$3.42

According to Capricor Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$3.51. In 2025 the company made an earnings per share (EPS) of C-$3.24 a decrease over its 2024 EPS that were of C-$1.72.

EPS history for Capricor Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$3.425.38%
2025C-$3.2488.33%
2024C-$1.72
2022C-$1.6935.63%
2021C-$1.25-7.45%
2020C-$1.35-55.45%
2019C-$3.03-59.81%
2018C-$7.53-1850%
2017C$0.43-102.94%
2016C-$14.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.58-372.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$10.00-384.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
C-$8.66 146.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$6.24 77.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
C-$10.83 208.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C-$42.00 1,095.51%๐Ÿ‡บ๐Ÿ‡ธ USA